For severe to critical 

Chiral Pharma Corporation started commercial operations on October 1, 2008.  The company participated in different Therapeutic Classes namely, Women’s Health, Cardio Metabolic, General, OTC and consumer, vaccines, and biologicals.  Eventually, Chiral was able to develop expertise in the vaccines and biologicals market and evolved into a niche focused and product centric business.  It engaged in the marketing of New Marketlink Pharmaceutical Corporation blockbuster vaccines and biologicals supplied by Novartis Vaccines, GSK, and Bharat Serums and Vaccines Limited.

Chiral Pharma Corporation (CPC) is a subsidiary of New Marketlink Pharmaceutical Corporation and a member of community of companies of Tao Corporation.

CPC is engaged in marketing and promotion of vaccines and biologicals in government (local and national) and private hospitals.   It is a partner of well-known companies in the field of vaccines and biologicals such as Serum Institute of India Ltd., Zydus and CytoDyn, Inc.

Consistent with its mother company New Marketlink Pharmaceutical Corporation, the mission of Chiral Pharma Corp. is to save lives and improve the health of the Filipino people.  This mission propels Chiral Pharma Corp. to be the best in the field of its expertise.